135 related articles for article (PubMed ID: 6224428)
21. Monocrotaline pyrrole-induced cardiopulmonary toxicity is not altered by metergoline or ketanserin.
Ganey PE; Sprugel KH; Hadley KB; Roth RA
J Pharmacol Exp Ther; 1986 Apr; 237(1):226-31. PubMed ID: 2937908
[TBL] [Abstract][Full Text] [Related]
22. Fibrinolytic activity in blood and lungs of rats treated with monocrotaline pyrrole.
Schultze AE; Roth RA
Toxicol Appl Pharmacol; 1993 Jul; 121(1):129-37. PubMed ID: 7687795
[TBL] [Abstract][Full Text] [Related]
23. Aggregation of platelets from monocrotaline pyrrole-treated rats.
Hilliker KS; Deyo JA; Bell TG; Roth RA
Thromb Res; 1983 Nov; 32(3):325-33. PubMed ID: 6419380
[TBL] [Abstract][Full Text] [Related]
24. 6-keto prostaglandin F1 alpha and thromboxane B2 in isolated, buffer-perfused lungs from monocrotaline pyrrole-treated rats.
Ganey PE; Roth RA
Exp Lung Res; 1987; 12(3):195-206. PubMed ID: 3107969
[TBL] [Abstract][Full Text] [Related]
25. Right ventricular performance after monocrotaline-induced pulmonary hypertension.
Werchan PM; Summer WR; Gerdes AM; McDonough KH
Am J Physiol; 1989 May; 256(5 Pt 2):H1328-36. PubMed ID: 2524170
[TBL] [Abstract][Full Text] [Related]
26. 6-Ketoprostaglandin F1 alpha and thromboxane B2 in isolated, blood-perfused lungs from monocrotaline pyrrole-treated rats.
Ganey PE; Roth RA
J Toxicol Environ Health; 1988; 23(1):127-37. PubMed ID: 3336057
[TBL] [Abstract][Full Text] [Related]
27. Lung vascular injury from monocrotaline pyrrole, a putative hepatic metabolite.
Roth RA; Reindel JF
Adv Exp Med Biol; 1991; 283():477-87. PubMed ID: 1906225
[TBL] [Abstract][Full Text] [Related]
28. Monocrotaline-induced cardiopulmonary injury in rats: modification by the nonthiol ACE inhibitors CGS13945 and CGS16617.
Molteni A; Ward WF; Ts'ao C; Solliday NH
Arch Int Pharmacodyn Ther; 1988; 291():21-40. PubMed ID: 3129998
[TBL] [Abstract][Full Text] [Related]
29. Hypertrophy and prolonged DNA synthesis in smooth muscle cells characterize pulmonary arterial wall thickening after monocrotaline pyrrole administration to rats.
Lappin PB; Roth RA
Toxicol Pathol; 1997; 25(4):372-80. PubMed ID: 9280120
[TBL] [Abstract][Full Text] [Related]
30. Platelets and the puzzles of pulmonary pyrrolizidine poisoning.
Roth RA; Ganey PE
Toxicol Appl Pharmacol; 1988 May; 93(3):463-71. PubMed ID: 3130680
[TBL] [Abstract][Full Text] [Related]
31. Preventive effects of raloxifene, a selective estrogen receptor modulator, on monocrotaline-induced pulmonary hypertension in intact and ovariectomized female rats.
Nishida M; Hasegawa Y; Tanida I; Nakagawa E; Inaji H; Ohkita M; Matsumura Y
Eur J Pharmacol; 2009 Jul; 614(1-3):70-6. PubMed ID: 19379725
[TBL] [Abstract][Full Text] [Related]
32. Elevated serum copper concentration in monocrotaline pyrrole treated rats with pulmonary hypertension.
Ganey PE; Roth RA
Biochem Pharmacol; 1987 Oct; 36(20):3535-7. PubMed ID: 3675611
[No Abstract] [Full Text] [Related]
33. Effect of a mixed function oxidase inducer and inhibitor on monocrotaline pyrrole pneumotoxicity.
Bruner LH; Carpenter LJ; Hamlow P; Roth RA
Toxicol Appl Pharmacol; 1986 Sep; 85(3):416-27. PubMed ID: 3094196
[TBL] [Abstract][Full Text] [Related]
34. Procoagulant and fibrinolytic properties of bovine endothelial cells treated with monocrotaline pyrrole.
Schultze AE; Roth RA
Toxicol Appl Pharmacol; 1993 Sep; 122(1):7-15. PubMed ID: 8378934
[TBL] [Abstract][Full Text] [Related]
35. Bioactivation of monocrotaline by P-450 3A in rat liver.
Kasahara Y; Kiyatake K; Tatsumi K; Sugito K; Kakusaka I; Yamagata S; Ohmori S; Kitada M; Kuriyama T
J Cardiovasc Pharmacol; 1997 Jul; 30(1):124-9. PubMed ID: 9268231
[TBL] [Abstract][Full Text] [Related]
36. Pathological analysis of the right ventricular hypertrophy and ventricular interdependence in autopsied hearts with cor pulmonale and pulmonary hypertensive rat hearts.
Sekine I; Takahashi M; Murata M; Kira Y; Okabe F; Ito T
Jpn Circ J; 1989 Oct; 53(10):1245-52. PubMed ID: 2533277
[TBL] [Abstract][Full Text] [Related]
37. Effects of monocrotaline pyrrole on cultured rat pulmonary endothelium.
Hoorn CM; Wagner JG; Roth RA
Toxicol Appl Pharmacol; 1993 Jun; 120(2):281-7. PubMed ID: 8511798
[TBL] [Abstract][Full Text] [Related]
38. Dose-response relationship in intoxication by the pyrrolizidine alkaloid monocrotaline.
Shubat PJ; Hubbard AK; Huxtable RJ
J Toxicol Environ Health; 1989; 28(4):445-60. PubMed ID: 2531804
[TBL] [Abstract][Full Text] [Related]
39. Polyamines and the development of monocrotaline-induced pulmonary hypertension.
Olson JW; Hacker AD; Altiere RJ; Gillespie MN
Am J Physiol; 1984 Oct; 247(4 Pt 2):H682-5. PubMed ID: 6437245
[TBL] [Abstract][Full Text] [Related]
40. Endothelial injury and vascular reactivity in monocrotaline pulmonary hypertension.
Rosenberg HC; Rabinovitch M
Am J Physiol; 1988 Dec; 255(6 Pt 2):H1484-91. PubMed ID: 3144186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
